PHARMACEUTICAL COMPOSITION SUITABLE FOR INFLUENCING THE RETICULOENDOTHELIAL SYSTEM AND FOR TREATING MUCOVISCIDOSIS AND CHRONIC PAIN SYNDROMES DERIVING FROM DEGENERATIVE LOCOMOTOR DISEASES OR ACCOMPANYING THE DISEASES OF TUMOROUS ORIGIN

摘要

The subject-matter of the invention is a pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying the diseases of tumorous origin, containing i) one or more pharmaceutically acceptable, water-soluble compounds of boron, fluorine, magnesium, vanadium, manganese, iron, cobalt, nickel, copper, zinc and molybdenum, which compounds do not precipitate with each other or with the other components of the composition and exhibit a neutral or acidic pH in an aqueous medium, ii) glycine, iii) glycerol, iv) L-(+)-ascorbic acid, vi) a neutral or acidic and water-soluble, pharmaceutically acceptable salt of ethylenediaminetetraacetic acid, and vii) potassium sodium tartrate, Optionally together with one or more usual pharmaceutical carrier(s), diluent(s) and/or auxiliary agent(s) characterized in that they also contain v) succinic acid and viii) L-(+)-tartaric acid.